Palatin Technologies Inc. (PTN)
PTN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$8.19
-4.21% on the day
Market cap
$14.6M
Nano cap
Revenue · 2025
$0
-100.0% on 2024
Net income · 2025
-$17.3M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PTN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000911216 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NJ |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$17.3M |
| Operating income | -$17.5M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | -100.0% |
| Cash | $14.5M |
| Total assets | $17.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B4 | 2025-11-12 |
| Latest annual report | 10-K | 2026-09-28 |
| Latest quarterly / interim | 10-Q | 2026-05-13 |
| Latest current report | 8-K | 2026-08-03 |
| Latest proxy | DEF 14A | 2026-06-25 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DARE | Dare Bioscience Inc. | $0.7477 | -0.32% | $14.7M |
| RKTO | Rocket One Inc. | $0.5708 | -4.85% | $14.2M |
| KTTA | Pasithea Therapeutics Corp. | $0.4238 | -5.30% | $14.2M |
| TVRD | Tvardi Therapeutics Inc. | $1.04 | -1.89% | $13.9M |
| ALLR | Allarity Therapeutics Inc. | $0.8699 | +1.14% | $13.8M |
| HIND | Vyome Holdings Inc. | $1.97 | -1.99% | $13.8M |
| MRKR | Marker Therapeutics Inc. | $0.9249 | -8.43% | $15.4M |
| GTBP | GT Biopharma Inc. | $6.50 | -4.41% | $13.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier